Reflecting on SPI Pharma’s 2023: A Year of Innovation and Growth
Dear Valued Partners,
As we wrap up an eventful 2023, we’re thrilled to share the incredible journey we’ve embarked on together at SPI Pharma. This year has been a testament to our commitment to innovation and progress in the pharmaceutical and nutritional industries.
In 2023, SPI Pharma made a mark globally by taking part in major trade shows worldwide. We showcased our innovations at events like CPhI and DCAT and connected with industry leaders at the World Vaccine Congress and SupplySide West, and many other events. Our goal was simple: to reach diverse markets and build partnerships in the pharmaceutical field. These shows gave us a chance to display our advanced solutions, share insights, and make important connections on a global scale. This helped us reinforce SPI Pharma's position as a leading company in the industry, committed to advancing pharmaceutical technologies and providing innovative solutions.
Adding to our achievements, the launch of new products like Actillets™, TAP®, S-Tab™ and new Saponin Based Adjuvants, brought a wave of excitement, while solving the needs of formulators. These new products represent our dedication to introducing advanced formulations that optimize performance and streamline production processes.
>>Read the full press release on ACTILLETS™, TAP®, and Directly Compressible Ibuprofen DC100
Along with the introduction of new products in 2023, the year also witnessed the forging of new partnerships. One noteworthy collaboration unfolded as SPI Pharma, Inc. and Q-Vant Biosciences, Inc. united in a strategic partnership. This alliance aims to provide broader access to sustainable and scalable pharma-grade saponin adjuvants. “The high quality, fully integrated sustainable supply of saponin adjuvants is a perfect addition to further enhance our portfolio and meet the needs of our pharmaceutical and veterinary customers," said Scott Thomson, CEO of SPI Pharma.
>>Read more about this strategic partnership here with Q-Vant Biosciences
Our excellent webinars in 2023 have also played a pivotal role in disseminating knowledge and fostering engagement within the industry. From insightful discussions on formulation advancements to in-depth explorations of pharmaceutical technologies, SPI Pharma's webinars have been a valuable resource for industry professionals seeking to stay abreast of the latest developments.
>>Watch our most recent webinar on S-Tab™: Breaking Ground With Direct Compression Tablets
This year we also released our groundbreaking UltraBurst™ eBook, a comprehensive guide to this great product, curated by our industry experts. Unlock the secrets of cutting-edge technology that empowers pharmaceutical professionals to develop ODTs with unprecedented speed and efficiency. This guide offers innovative approaches, expert insights, and practical best practices to streamline your development process. Learn how UltraBurst™ can save you time without compromising quality, making it an invaluable resource for professionals in the pharmaceutical field. Don't miss this opportunity to stay ahead in the industry.
>> Download your copy of our UltraBurst eBook
We genuinely thank you for your unwavering support and commitment to SPI Pharma throughout this remarkable year. Looking ahead to 2024, we are excited about continuing this journey together, aiming to achieve new milestones and shared successes.
Thank you for being an integral part of SPI Pharma’s achievements.
Warm regards,
The SPI Pharma Team